Disclosure Of Entity's Operating Segments [Text Block]

BerGenBio - Filing #2542730

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Disclosure of entity's operating segments [text block]	—	—		—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	—	354,000 NOK	—	—	—	—	—	389,000 NOK	—	—	—
Tax expense (income)	—	—	0 NOK	—	—	—	—	—	0 NOK	—	—	—
Profit (loss) before tax	—	—	190,401,000 NOK	—	—	—	—	—	302,122,000 NOK	—	—	—
Profit (loss)	0 NOK	0 NOK	190,401,000 NOK	—	190,401,000 NOK	0 NOK	—	0 NOK	302,122,000 NOK	302,122,000 NOK	0 NOK	0 NOK
Assets	—	—	—	174,335,000 NOK	—	—	166,706,000 NOK	—	—	—	—	—
Liabilities	—	—	—	46,859,000 NOK	—	—	78,208,000 NOK	—	—	—	—	—
Cash flows from (used in) operating activities	—	—	225,101,000 NOK	—	—	—	—	—	288,231,000 NOK	—	—	—
Cash flows from (used in) investing activities	—	—	3,055,000 NOK	—	—	—	—	—	3,248,000 NOK	—	—	—
Cash flows from (used in) financing activities	—	—	224,884,000 NOK	—	—	—	—	—	2,904,000 NOK	—	—	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]